Lv1
30 积分 2024-05-20 加入
Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy
4个月前
已完结
BCMA biology and therapeutic targeting in multiple myeloma: From ligand signaling to antigen escape
7个月前
已完结
Multiple myeloma
7个月前
已完结
Forks in the road for CAR T and CAR NK cell cancer therapies
8个月前
已完结
Human pluripotent stem cell-derived innate and adaptive immune cells for cancer immunotherapy
8个月前
已完结
The GDNF family: Signalling, biological functions and therapeutic value
9个月前
已完结
Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
9个月前
已完结
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
9个月前
已完结
Chimeric Antigen Receptor Therapy
10个月前
已完结
Adoptive cell transfer as personalized immunotherapy for human cancer
10个月前
已完结
皖公网安备34019202002308
